Refractory Ventricular Tachycardia

  • Charles Love
Part of the Contemporary Internal Medicine book series (COIM, volume 3)


P.W. is a 57-year-old white man who was in good health until 1972, when he suffered an acute anterior myocardial infarction. His immediate postinfarction course was uncomplicated. He did well for the next two years, when he then began to have symptoms of progressive dyspnea and fatigue. Subsequent physical examination revealed a systolic murmur, and further evaluation proved this to be severe calcific aortic stenosis. He underwent aortic valve replacement in March of 1978 with a Starr-Edwards prosthesis. At this time he developed intraoperative and postoperative runs of ventricular tachycardia (VT). He was treated with propranolol and quinidine with resolution of the arrhythmia. The medications were discontinued after discharge as the rhythm disturbance was felt to be related to the stress of the operative procedure.


Ventricular Tachycardia Ventricular Ectopy Arrhythmogenic Right Ventricular Dysplasia Program Stimulation Monomorphic Ventricular Tachycardia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Josepheson ME, et al: Recurrent sustained ventricular tachycardia: I. Mechanisms. Circulation. 1976;57:431.CrossRefGoogle Scholar
  2. 2.
    Josepheson ME, et al: Sustained ventricular tachycardia in coronary artery disease: Evidence for a reentrant mechanism, in Zipes DP, Jalife J (eds): Cardiac Electrophysiology and Arrhythmias, Orlando, Grune and Stratton, 1985, pp 409–418.Google Scholar
  3. 3.
    Brugada P, Wellens JHH: The role of triggered activity in clinical ventricular arrhythmias. PACE. 1984;7:260.PubMedCrossRefGoogle Scholar
  4. 4.
    Fogoros RN, et al: The automatic implantable cardioverter defibrillator in drug refractory ventricular tachycardia. Ann Intern Med. 1987;107:635–641.PubMedCrossRefGoogle Scholar
  5. 5.
    Hall PAX, et al: The signal averaged surface electrocardiogram and the identification of late potentials. Prog Cardiovasc Dis. 1989;31:295–317.PubMedCrossRefGoogle Scholar
  6. 6.
    Fisher JD: Role of electrophysiologic testing in the diagnosis and treatment of patients with known and suspected bradycardias and tachycardias. Prog Cardiovasc Dis. 1981;24:25.PubMedCrossRefGoogle Scholar
  7. 7.
    MKSAP, Medical Knowledge Self-Assessment Program VIII, 1988, pp 830-831.Google Scholar
  8. 8.
    Vaughan-Williams EM: Classification of antiarrhythmic drugs in Sandow E, Flenstedt-Jensen E, Olesen KH (eds): Sweden, Sodertalje, Cardiac Arrhythmias. 1970.Google Scholar
  9. 9.
    Naccarelli GV, et al: Amiodarone: Pharmacology and antiarrhythmic and adverse effects. Pharmacotherapy. 1985;5:298–313.PubMedGoogle Scholar
  10. 10.
    Preliminary Report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. CAST investigators. N Engl J Med. 1989;321:406–412.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Charles Love

There are no affiliations available

Personalised recommendations